The Japanese firm was to launch the offer for 20% of Ranbaxy on August 8, but said on July 31 the schedule had been delayed as the market regulator SEBI had not approved it by then.
Earlier on June 16, the Japanese firm, which had agreed to acquire the promoters` 34.8% stake in Ranbaxy, had made an open offer for acquiring up to 92.1 million shares, representing 20% stake in Ranbaxy at a price of Rs 737 each.
No comments:
Post a Comment